Nematode Infections

Back

Background

Nematode infections in humans include ascariasis, trichuriasis, hookworm, enterobiasis, strongyloidiasis, filariasis, trichinosis, dirofilariasis, and angiostrongyliasis (rat lungworm disease), among others. The phylum Nematoda, also known as the roundworms, is the second largest phylum in the animal kingdom, encompassing up to 500,000 species. Members of Nematoda are elongated, with bilaterally symmetric bodies that contain an intestinal system and a large body cavity.

Many roundworm species are free living in nature. Recent data have demonstrated that approximately 60 species of roundworms parasitize humans. Intestinal roundworm infections constitute the largest group of helminthic diseases in humans. According to a 2005 report by the World Health Organization (WHO), approximately 0.807-1.221 billion humans have ascariasis, 604-795 million have trichuriasis, and 576-740 million have hookworm infections worldwide.[1]

Pathophysiology

The life cycle of parasitic nematodes is clinically important. Some nematode infections can be transmitted directly from infected to uninfected people; in others, the nematode eggs must undergo a process of maturation outside the host. In a third category, the parasites may spend a part of their life cycle in the soil before becoming infective to humans.

As with other parasitic infections, definitive diagnosis of nematode infections depends on demonstration of the stage of the life cycle in the host. Nematodes, as with most other worms infectious to humans, almost never complete their entire life cycle in the human host.

The life cycles of nematodes are complex and highly varied. Some species, including Enterobius vermicularis, can be transmitted directly from person to person, while others, such as Ascaris lumbricoides, Necator americanus, and Ancylostoma duodenale, require a soil phase for development. Because most helminthic parasites do not self-replicate, the acquisition of a heavy burden of adult worms requires repeated exposure to the parasite in its infectious stage, whether larva or egg. Hence, clinical disease, as opposed to asymptomatic infection, generally develops only with prolonged residence in an endemic region.

Unlike with protozoan infections, a casual or a low degree of exposure to infective stages of parasitic nematodes usually does not result in patent infection or pathologic findings. Repeated or intense exposure to a multitude of infective stage larvae is required for infection to be established and disease to arise. Anisakis species cause erosive and/or hemorrhagic lesions in or near the main lesion, forming a tunnel through the gastric mucosa to the submucosa.

Eosinophilia and elevated serum immunoglobulin E (IgE) levels are features of many nematode infections; when unexplained, these symptoms should always prompt a search for occult roundworm infection. Humans do not appear to develop significant protective immunity to intestinal nematodes, although the mechanisms of parasite immune evasion and host immune responses to these infections have not been elucidated in detail.

Epidemiology

Frequency

United States

Trichuriasis: Recent estimates indicate that 2.2 million people in the United States are infected with Trichuris trichiura (whipworm), mainly in the rural Southeast.

Enterobiasis: This is the most common of all helminthic infections, with an estimated 42 million cases.

Ascariasis: An estimated 4 million people, mainly in the Southeast, are infected with Ascaris species.

Hookworm: This infection still has a low degree of prevalence in the Southeast.

Strongyloidiasis: A prevalence rate of 0.4-4% has been estimated in southern states.

Trichinosis: The prevalence rate is 4-20%.

Anisakiasis: Annually, fewer than 10 cases occur in the United States.

Dirofilariasis: A total of 116 cases have been reported, originating primarily in the southeast regions in the United States.[2]

Angiostrongyliasis (rat lungworm disease): This is a rare infection that has been reported in Hawaii and Louisiana.[3]

International

According to a WHO analysis, intestinal nematode infections are most prevalent in Asia, with roughly 67% of cases.[4]

Trichuriasis: Infection with T trichiura is one of the most prevalent nematode infections worldwide; approximately 800 million persons have trichuriasis worldwide, most abundantly in warm moist regions. Infection rates of up to 75% were found in young schoolchildren in Puerto Rico.

Enterobiasis: Pinworm is also highly prevalent throughout the world, particularly in countries of the temperate zone. Children are most commonly infected. Estimated prevalence rates among children in various world regions are 4–28%.

Ascariasis: Ascaris, or roundworm, infection is the common helminthic infection in humans, with an estimated worldwide prevalence of 1 billion. The causative organism, A lumbricoides, is cosmopolitan in distribution, being most abundant in tropical countries.

Hookworm: Human infection with the 2 species of hookworm, A duodenale and N americanus, is estimated to affect approximately 550-750 million people.[5]

Strongyloidiasis: The infection is more common in tropical countries with poor sanitation, especially in countries of Southeast Asia and parts of Africa. Strongyloides stercoralis is also endemic in Jamaica and presumably elsewhere in the Caribbean. An estimated 30-100 million persons worldwide have strongyloidiasis. The prevalence of S stercoralis infection among individuals with HIV infection is 5.1%.[6]

Trichinosis: Trichinella species are distributed throughout the world and are spread widely in nature among a large number of carnivorous animals, with humans acting as an incidental host. Trichinosis has been a major public health problem and has been reported in many Asian countries, including China, Japan, Korea, and Thailand.

Dracunculiasis: Estimates of the number of people infected with Dracunculus medinensis in Africa, the Middle East, India, and other tropical areas range from 50-150 million. An aggressive eradication campaign has been underway to eliminate D medinensis, which is called the Guinea worm.

Filariasis: An estimated 120 million people are infected with Wuchereria bancrofti, Brugia malayi, and Brugia timori.

Loiasis: Loa loa is irregularly distributed in Africa. It is estimated that between 3 and 13 million people in West and Central Africa are infected.

Onchocerciasis: Onchocerca volvulus infects 20 million people in West, Central, and East Africa and another 1 million people in scattered foci in Central America and South America. The disease caused by this filarial worm is called river blindness.

Anisakiasis: Approximately 20,000 cases of anisakiasis are reported annually worldwide; over 90% are from Japan and most others from Spain, the Netherlands, and Germany, depending on the habits of fish consumption.[7]

Dirofilariasis: The highest incidence of human cases has been recorded in Mediterranean countries (Italy, southern France, Greece). Dirofilariasis has been reported in some eastern European countries, namely Ukraine, Russian Federation, and Belarus, in the last two decades. Italy has the most number of cases of human dirofilariasis.[8]

Angiostrongyliasis (rat lungworm disease): This is an uncommon infection that mostly affects the Pacific Basin and Southeast Asia. Isolated cases have been reported in the Caribbean, Africa, and Australia.[3]

Mortality/Morbidity

Nematode infections are usually asymptomatic or subclinical.

Strongyloidosis may be fatal in immunocompromised patients and in newborns.

Intestinal nematodes can cause some GI problems (eg, abdominal pain, diarrhea, anorexia, weight loss, malaise).

Hookworms can cause serious anemia.

Onchocerciasis can result in blindness (river blindness).

Trichinosis can cause life-threatening manifestations, including myocarditis, CNS involvement, and pneumonitis.

Larvae of Anisakis species may become embedded in the gastric mucosa; endoscopy may reveal erythema, edema, severe erosive gastritis, a tumorlike nodule, or ulcerations. Anisakiasis has been reported to be associated with allergy reactions in some individuals.[9]

Patients with ocular dirofilariasis often report discomfort, ocular pain, grittiness, and eye redness.[10]

Angiostrongyliasis (rat lungworm disease) has a presentation similar to that of bacterial meningitis. Rarely, neurologic dysfunction or death can occur.[3]

Some of the more serious nematode infections result in symptoms from inflammatory responses in vital organs and nutritional deficiencies.

Race

Nematode infections have no known racial predilection.

Sex

Nematode infections have no known sexual predilection.

Age

E vermicularis infection (pinworm) is more common in children than in adults.

Prognosis

Light-to-moderate nematode infections carry a good prognosis. Prognosis depends on the organ infected and the extent of the infection.

Ascariasis should always be treated because of the risk of migrating adult worms.

Long-term diethylcarbamazine treatment and immunomonitoring of patients with filariae are essential in endemic areas to arrest and prevent pathology.

Angiostrongyliasis (rat lungworm disease) typically resolves without treatment.[3]

Patient Education

Avoid fecally contaminated food, water, and soil.

Avoid bites by arthropod vectors. Use insect repellants and other protective measures, eg, proper clothing.

Avoid rivers, streams, and soils known to be infected.

History

Several clinical signs and symptoms can occur in patients with nematode infections.

Physical

T trichiura infections

In heavily infected people, trichuriasis appears to manifest as mild anemia, eosinophilia, bloody diarrhea (classic trichuris dysentery syndrome), growth retardation (chronic trichuris colitis with growth retardation), abdominal pain, finger clubbing, and rectal prolapse (especially in children). See the image below.



View Image

A typical Trichuris trichiura egg in feces.

E vermicularis infection (pinworm)

The most common symptom of pinworm infection is nocturnal perianal pruritus. Occasionally, the migration of the parasite produces ectopic disease (eg, appendicitis, vulvovaginitis, chronic salpingitis, ulcerative lesions in the small or large bowel).[11] Enuresis has been blamed on the pinworm.

A lumbricoides infection

A more serious complication of ascariasis is encountered when a mass of worms obstructs the lumen of the small bowel. This acute abdominal condition is commonly observed in children with heavy infections. The presentation is similar to that of acute intestinal obstruction, with vomiting, abdominal distention, and cramps.

Another obstructive syndrome is encountered when Ascaris worms invade the biliary duct and cause pancreatic-biliary ascariasis. The most common presenting feature is abdominal pain, observed in 98% of patients. Less common features include ascending cholangitis, acute pancreatitis, and, rarely, obstructive jaundice.

Ascariasis in pregnant women results in intrauterine growth retardation. See the image below.



View Image

Ascaris lumbricoides egg in feces (formalin-ethyl acetate sedimentation method).

Hookworms

The major manifestations of hookworm disease include iron deficiency anemia and chronic protein energy malnutrition. The development of these clinical features depends not only on the worm burden but also on the amount of absorbable dietary iron.

During the phase of worm attachment to small intestine mucosa, abdominal pain, diarrhea, and weight loss may be noted. In addition, malabsorption has been reported in children and, less commonly, in adults.[12]

S stercoralis infection

Burning or colicky abdominal pain, often epigastric, occurs and is associated with diarrhea and the passage of mucus.

Some patients with strongyloidiasis report nausea, vomiting, and weight loss, with evidence of malabsorption or of protein-losing enteropathy.

Massive larval invasion of the lungs and other tissues may occur with hyperinfection, usually in immunocompromised hosts. In this syndrome, the worm is able to complete its entire life cycle in the human, and the symptoms are related to the large burden of larvae migrating in the host.

Severe generalized abdominal pain, diffuse pulmonary infiltrates, ileus, shock, and meningitis or sepsis due to gram-negative bacilli may occur. See the image below.



View Image

Strongyloides eggs in native examination from feces of a newborn.

T spiralis infection

Myositis with pain, swelling, and weakness is common; it usually first develops in the extraocular muscles and then involves the masseters, neck muscles, limb flexors, and lumbar muscles. Some patients report headache, cough, shortness of breath, hoarseness, and dysphagia.

Anisakiasis

The ingestion of a parasitized fish with a nematode of the Anisakis genus may elicit symptoms within few hours.

Four principal clinical syndromes associated to anisakiasis have been described: gastric, intestinal, ectopic (or extragastrointestinal), and allergic. The onset of gastric anisakiasis begins within a few hours (generally 1 to 2 hours), when a live Anisakis larva reaches the human stomach.

Acute phase of the infection elicits severe epigastric pain, vomiting, diarrhea, and a mild fever. Generally, acute symptoms resolve within a few days, but untreated gastric disease can lead to chronic ulcerlike symptoms lasting for weeks to months.

Rare complications include small bowel obstruction, ileal stenosis, intussusception, intestinal perforation, and pneumoperitoneum.

Dirofilariasis

Dirofilaria species are nematodes that infect domestic and wild canids, transmitted by several species of mosquitoes. Dirofilaria immitis causes severe disease (heartworm disease) in dogs and other carnivores and occasionally infects humans, while Dirofilaria repens usually causes a nonpathogenic subcutaneous infection in dogs and is the principal agent of human dirofilariasis in the Old World.

Dirofilariasis causes two main clinical syndromes: pulmonary dirofilariasis (caused by D immitis) and ocular or subcutaneous dirofilariasis (caused by several different dirofilarial species, particularly D repens). In addition to these syndromes, human dirofilariasis has been reported at other sites, such as the central nervous system, male genital system, peritoneal cavity, liver, or buccal mucosa.[8]

The diagnosis of Dirofilaria infection in humans is affected by the localization of the worm and the clinical symptoms. Serological investigations are not helpful in human cases.

The nematode can be removed via surgery, a practice that is also needed for etiological diagnosis and the exclusion of other severe diseases.[13]



View Image

Dirofilaria repens: A. Front end (x400), B. Macroscopic size.



View Image

Dirofilaria from a scalp nodule.

Angiostrongyliasis (rat lungworm disease)

Angiostrongylus cantonensis infection has a presentation similar to that of bacterial meningitis (eg, nausea/vomiting, stiff neck, headaches). The infection can last from 2-8 weeks (or longer) but usually self-resolves without treatment.[3]

Causes

The following are potential causes of nematode infections:

Complications

Potential complications of nematode infections are as follows:

Approach Considerations

Several approaches are available to identify nematodes, from the basic traditional morphological identification methods to the more complex high-throughput sequencing technologies. The morphological and morphometric features allow identification of nematodes within their respective genus. The species can be identified based on the morphological features of the sexual organs of adult male nematodes.

The morphology of the eggs or larvae collected from feces, along with any clinical symptoms, is usually sufficient to diagnose a human nematode infection.

The detection of an antibody response mounted toward a nematode infection constitutes another frequently used diagnostic strategy. Sensitive immunological methods such as enzyme-linked immunosorbent assay (ELISA) are useful to detect antibodies in the serum.[14]

Molecular methods are effective for identification of nematodes. Polymerase chain reaction (PCR)–based methods and multiplex PCR have provided solutions in problems related to differential diagnosis.[15]

Laboratory Studies

Laboratory studies are as follows:

Imaging Studies

Imaging studies are as follows:

Other Tests

Onchocerciasis: Skin snip, nodulectomy, slit-lamp examination, and Mazzotti test are helpful.

Histologic Findings

Characteristic eggs, worms, or larvae in tissue

Medical Care

Nematode infections need to be identified and treated accordingly.

In dracunculiasis, the best treatment is direct removal of worms from tissue, taking care not to break the worm.

Treat secondary infections.

Surgical Care

Acute intestinal obstruction and perforation in patients with ascariasis may require surgical treatment.

Long-standing lymphatic filariasis due to W bancrofti and B malayi infection may require surgical intervention to increase lymphatic drainage. This is unusual and likely observed in long-term residents of endemic areas who have been subjected to extensive exposure to the parasite.

Consultations

Consultations are as follows:

Diet

No special diet is required.

Activity

No restrictions are necessary. In lymphatic filariasis, if edema is a problem, the patient may want to elevate legs while sitting.

Prevention

Preventive measures are as follows:

Further Outpatient Care

Patients who have undergone treatment for nematode infections should undergo follow-up stool studies at 2 weeks and re-treatment, if necessary.

Medication Summary

The goals of pharmacotherapy are to eradicate the infestation, to reduce morbidity, and to prevent complications.[16]

Albendazole (Albenza)

Clinical Context:  Used for hookworm, pinworm, and roundworm. Decreases ATP production in worm, causing energy depletion, immobilization, and, finally, death.

Mebendazole (Vermox)

Clinical Context:  Indicated for treating E vermicularis (pinworm), T trichiura (whipworm), A lumbricoides (common roundworm), A duodenale (common hookworm), N americanus (American hookworm) in single or mixed infections. Efficacy varies as a function of such factors as preexisting diarrhea and GI transit time, degree of infection, and helminth strains. Causes worm death by selectively and irreversibly blocking uptake of glucose and other nutrients in susceptible adult intestine where helminths dwell.

Ivermectin (Mectizan)

Clinical Context:  Member of avermectin class (broad-spectrum antiparasitic agents). Unique mode of action. Binds selectively with high affinity to glutamate-gated chloride ion channels in invertebrate nerve and muscle cells. Increases permeability of cell membrane to chloride ions. Results in hyperpolarization of nerve or muscle cell, causing parasite paralysis and death. Also affects other ligand-gated chloride channels (eg, those gated by GABA). Active against various life-cycle stages of most nematodes. Active against O volvulus tissue microfilariae but not adult form. Activity against S stercoralis limited to intestinal stages.

Piperazine (Vermizine)

Clinical Context:  Readily absorbed from GI tract, partially degraded in vivo, and excreted in urine. Paralyzes worm muscle; thus, worm expelled by normal intestinal peristalsis. Exhibits wide therapeutic index. Not available in the United States.

Pyrantel pamoate (Antiminth, Pin-Rid)

Clinical Context:  Depolarizing neuromuscular blocking agent and cholinesterase inhibitor that results in spastic paralysis of worm. Active against E vermicularis (pinworm), A lumbricoides (roundworm), and A duodenale (hookworm).

Diethylcarbamazine citrate (Hetrazan)

Clinical Context:  Effective in treating filariasis specific for W bancrofti, B malayi, and L loa. Does not contain any toxic metallic elements. Not recommended as DOC because of severe adverse effects. Recommended if therapy with mebendazole fails or unavailable.

Class Summary

Parasite biochemical pathways are different from the human host; thus, toxicity is directed to the parasite, egg, or larvae. Mechanism of action varies within the drug class. Antiparasitic actions may include the following:

- Inhibition of microtubules, causing irreversible block of glucose uptake

- Tubulin polymerization inhibition

- Depolarizing neuromuscular blockade

- Cholinesterase inhibition

- Increased cell membrane permeability, resulting in intracellular calcium loss

- Vacuolization of the schistosome tegument

- Increased cell membrane permeability to chloride ions via chloride channels alteration

Author

Murat Hökelek, MD, PhD, Professor, Department of Clinical Microbiology, Istanbul University Cerrahpasa Medical Faculty, Turkey

Disclosure: Nothing to disclose.

Coauthor(s)

Arnold C Cua, MD, Physician, Department of Infectious Diseases, Renown Medical Center

Disclosure: Nothing to disclose.

Larry I Lutwick, MD, FACP, Editor-in-Chief, ID Cases; Moderator, Program for Monitoring Emerging Diseases; Adjunct Professor of Medicine, State University of New York Downstate College of Medicine

Disclosure: Nothing to disclose.

Specialty Editors

Francisco Talavera, PharmD, PhD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Chief Editor

Michael Stuart Bronze, MD, David Ross Boyd Professor and Chairman, Department of Medicine, Stewart G Wolf Endowed Chair in Internal Medicine, Department of Medicine, University of Oklahoma Health Science Center; Master of the American College of Physicians; Fellow, Infectious Diseases Society of America; Fellow of the Royal College of Physicians, London

Disclosure: Nothing to disclose.

Additional Contributors

Joseph R Masci, MD, FACP, FCCP, Professor of Medicine, Professor of Preventive Medicine, Icahn School of Medicine at Mount Sinai; Director of Medicine, Elmhurst Hospital Center

Disclosure: Nothing to disclose.

References

  1. Deworming for health and development. Report of the third global meeting of the partners for parasite control. 2005;
  2. Simón F, Siles-Lucas M, Morchón R, González-Miguel J, Mellado I, Carretón E, et al. Human and animal dirofilariasis: the emergence of a zoonotic mosaic. Clin Microbiol Rev. 2012 Jul. 25 (3):507-44. [View Abstract]
  3. Centers for Disease Control and Prevention. Parasites - Angiostrongyliasis (also known as Angiostrongylus Infection). CDC. Available at https://www.cdc.gov/parasites/angiostrongylus/epi.html. December 28, 2015; Accessed: May 15, 2017.
  4. Pisarski K. The Global Burden of Disease of Zoonotic Parasitic Diseases: Top 5 Contenders for Priority Consideration. Trop Med Infect Dis. 2019 Mar 2. 4 (1):[View Abstract]
  5. Dori GU, Tullu KD, Ali I, Hirko A, Mekuria G. Prevalence of hookworm infection and its association with anemia among patients visiting Fenan Medical Center, East Wollega Zone, Ethiopia. Ethiop Med J. 2011 Jul. 49(3):265-71. [View Abstract]
  6. Ahmadpour E, Ghanizadegan MA, Razavi A, Kangari M, Seyfi R, Shahdust M, et al. Strongyloides stercoralis infection in human immunodeficiency virus-infected patients and related risk factors: A systematic review and meta-analysis. Transbound Emerg Dis. 2019 Jul 29. [View Abstract]
  7. Pravettoni V, Primavesi L, Piantanida M. Anisakis simplex: current knowledge. Eur Ann Allergy Clin Immunol. 2012 Aug. 44(4):150-6. [View Abstract]
  8. Capelli G, Genchi C, Baneth G, Bourdeau P, Brianti E, Cardoso L, et al. Recent advances on Dirofilaria repens in dogs and humans in Europe. Parasit Vectors. 2018 Dec 19. 11 (1):663. [View Abstract]
  9. Aibinu IE, Smooker PM, Lopata AL. Anisakis Nematodes in Fish and Shellfish- from infection to allergies. Int J Parasitol Parasites Wildl. 2019 Aug. 9:384-393. [View Abstract]
  10. Beden U, Hokelek M, Acici M, Umur S, Gungor I, Sullu Y. A case of orbital dirofilariasis in Northern Turkey. Ophthalmic Plast Reconstr Surg. 2007 Jul-Aug. 23 (4):329-31. [View Abstract]
  11. Rawla P, Sharma S. Enterobius Vermicularis (Pinworm). 2019 Jan. [View Abstract]
  12. Zaph C, Cooper PJ, Harris NL. Mucosal immune responses following intestinal nematode infection. Parasite Immunol. 2014 Sep. 36(9):439-52. [View Abstract]
  13. Oliva A, Gabrielli S, Pernazza A, Pagini A, Daralioti T, Mantovani S, et al. Dirofilaria repens Infection Mimicking Lung Melanoma Metastasis. Open Forum Infect Dis. 2019 Mar. 6 (3):ofz049. [View Abstract]
  14. Seesao Y, Gay M, Merlin S, Viscogliosi E, Aliouat-Denis CM, Audebert C. A review of methods for nematode identification. J Microbiol Methods. 2017 Jul. 138:37-49. [View Abstract]
  15. Wong SSY, Poon RWS, To KKW, Chan JFW, Lu G, Xing F, et al. Improving the specific diagnosis of trematode, cestode and nematode infections by a multiplex single-tube real-time PCR assay. J Clin Pathol. 2019 Jul. 72 (7):487-492. [View Abstract]
  16. Peddibhotla S, Leung CK, Maloney P, Hershberger PM, Nguyen K, Vasile S, et al. A high throughput screen for inhibitors of nematode detoxification genes. 2013. [View Abstract]
  17. Basanez MG, Pion SD, Boakes E, et al. Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. Lancet Infect Dis. 2008 May. 8(5):310-22. [View Abstract]
  18. Bennett A, Guyatt H. Reducing intestinal nematode infection: efficacy of albendazole and mebendazole. Parasitol Today. 2000 Feb. 16(2):71-4. [View Abstract]
  19. Bethony J, Brooker S, Albonico M, et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet. 2006 May 6. 367(9521):1521-32. [View Abstract]
  20. Bradley JE, Jackson JA. Immunity, immunoregulation and the ecology of trichuriasis and ascariasis. Parasite Immunol. 2004 Nov-Dec. 26(11-12):429-41. [View Abstract]
  21. Brooker S, Bethony J, Hotez PJ. Human hookworm infection in the 21st century. Adv Parasitol. 2004. 58:197-288. [View Abstract]
  22. Crompton DW. Ascaris and ascariasis. Adv Parasitol. 2001. 48:285-375. [View Abstract]
  23. Garcia LS. Garcia LS. Diagnostic Medical Parasitology. 5th ed. Washington, DC: ASM Press; 2007. 249-356.
  24. Gilbert DN, Moellering RC Jr, Eliopoulos GM, et al. The Sanford Guide to Antimicrobial Therapy. 38th ed. Vermont: Antimicrobial Therapy Inc; 2008. 128-129.
  25. Grencis RK, Cooper ES. Enterobius, trichuris, capillaria, and hookworm including ancylostoma caninum. Gastroenterol Clin North Am. 1996 Sep. 25(3):579-97. [View Abstract]
  26. Hassan AN. Bancroftian filariasis: spatial patterns, environmental correlates and landscape predictors of disease risk. J Egypt Soc Parasitol. 2004 Aug. 34(2):501-13. [View Abstract]
  27. Holden-Dye L, Walker RJ. Anthelmintic drugs. WormBook. 2007 Nov 2. 1-13. [View Abstract]
  28. Hotez P. Hookworm and poverty. Ann N Y Acad Sci. 2008 Jun. 1136:38-44. [View Abstract]
  29. Huppatz C, Durrheim D, Lammie P, et al. Eliminating lymphatic filariasis--the surveillance challenge. Trop Med Int Health. 2008 Mar. 13(3):292-4. [View Abstract]
  30. Keiser J, Utzinger J. Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. JAMA. 2008 Apr 23. 299(16):1937-48. [View Abstract]
  31. King CH. Helmintic Diseases. Goldman: Cecil Textbook of Medicine. 21st ed. Philadelphia, Pa: WB Saunders; 2000. 1984-94.
  32. Mahmoud AAF. Intestinal Nematodes (Roundworms). Mandell: Principles and Practice of Infectious Diseases. 5th ed. London: Churchill Livingstone; 2000. 2938-2949.
  33. Massara CL, Enk MJ. Treatment options in the management of Ascaris lumbricoides. Expert Opin Pharmacother. 2004 Mar. 5(3):529-39. [View Abstract]
  34. Mitreva M, Jasmer DP. Biology and genome of Trichinella spiralis. WormBook. 2006 Nov 23. 1-21. [View Abstract]
  35. Morrison DA, Hoglund J. Testing the hypothesis of recent population expansions in nematode parasites of human-associated hosts. Heredity. 2005 Apr. 94(4):426-34. [View Abstract]
  36. Negrao-Correa D, Teixeira MM. The mutual influence of nematode infection and allergy. Chem Immunol Allergy. 2006. 90:14-28. [View Abstract]
  37. Omura S, Crump A. The life and times of ivermectin - a success story. Nat Rev Microbiol. 2004 Dec. 2(12):984-9. [View Abstract]
  38. Owen RL. Parasitic Diseases. Feldman: Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 6th ed. Philadelphia, Pa: WB Saunders; 1998. 1663-9.
  39. Pozio E. World distribution of Trichinella spp. infections in animals and humans. Vet Parasitol. 2007 Oct 21. 149(1-2):3-21. [View Abstract]
  40. Pozio E, Darwin Murrell K. Systematics and epidemiology of trichinella. Adv Parasitol. 2006. 63:367-439. [View Abstract]
  41. Pozio E, Gomez Morales MA, Dupouy-Camet J. Clinical aspects, diagnosis and treatment of trichinellosis. Expert Rev Anti Infect Ther. 2003 Oct. 1(3):471-82. [View Abstract]
  42. Quinnell RJ, Bethony J, Pritchard DI. The immunoepidemiology of human hookworm infection. Parasite Immunol. 2004 Nov-Dec. 26(11-12):443-54. [View Abstract]
  43. Segarra-Newnham M. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection. Ann Pharmacother. 2007 Dec. 41(12):1992-2001. [View Abstract]
  44. Viney ME, Lok JB. Strongyloides spp. WormBook. 2007 May 23. 1-15. [View Abstract]
  45. Walker MD, Zunt JR. Neuroparasitic infections: nematodes. Semin Neurol. 2005 Sep. 25(3):252-61. [View Abstract]

A typical Trichuris trichiura egg in feces.

Ascaris lumbricoides egg in feces (formalin-ethyl acetate sedimentation method).

Strongyloides eggs in native examination from feces of a newborn.

Dirofilaria repens: A. Front end (x400), B. Macroscopic size.

Dirofilaria from a scalp nodule.

Strongyloides eggs in native examination from feces of a newborn.

Ascaris lumbricoides egg in feces (formalin-ethyl acetate sedimentation method).

A typical Trichuris trichiura egg in feces.

Dirofilaria repens: A. Front end (x400), B. Macroscopic size.

Dirofilaria from a scalp nodule.